Understanding stem cell immunogenicity in therapeutic applications

Understanding stem cell immunogenicity in therapeutic applications

Stem cells and their differentiated progeny offer great hope for treating disease by providing an unlimited source of cells for repairing or replacing damaged tissue. Initial studies suggested that, unlike 'normal' transplants, specific characteristics of stem cells enabled them to avoid i...

Полное описание

Библиографические подробности
Главные авторы:	Wood, K, Issa, F, Hester, J
Формат:	Journal article
Язык:	English
Опубликовано:	Cell Press 2015

Схожие документы

Immunogenicity of embryonic stem cell-derived progenitors after transplantation.
по: English, K, и др.
Опубликовано: (2011)

Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.
по: Milward, K, и др.
Опубликовано: (2013)

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
по: Alzhrani, A, и др.
Опубликовано: (2020)

Revealing the Therapeutic Potential of Stem Cells in Burn Healing: A Deeper Understanding of the Therapeutic Mechanisms of Epidermal Stem Cells and Mesenchymal Stem Cells
по: Jianyu Lu, и др.
Опубликовано: (2024-01-01)

Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy
по: Durga Khandekar, и др.
Опубликовано: (2019-04-01)

Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model.
по: Issa, F, и др.
Опубликовано: (2012)

Understanding cancer stem cells and plasticity: Towards better therapeutics
по: Neerada Meenakshi Warrier, и др.
Опубликовано: (2023-06-01)

Exploitation of herpesvirus immune evasion strategies to modify the immunogenicity of human mesenchymal stem cell transplants.
по: Anabel S de la Garza-Rodea, и др.
Опубликовано: (2011-01-01)

Immunogenic cell death in cancer: concept and therapeutic implications
по: Lorenzo Galluzzi, и др.
Опубликовано: (2023-03-01)

Immunogenicity of CAR-T Cell Therapeutics: Evidence, Mechanism and Mitigation
по: Aalia N. Khan, и др.
Опубликовано: (2022-05-01)

Therapeutic implications of immunogenic cell death in human cancer
по: Fabio ePalombo, и др.
Опубликовано: (2014-01-01)

Regulatory T cells for tolerance
по: Kawai, K, и др.
Опубликовано: (2017)

Hematopoietic stem cells: Understanding the mechanisms to unleash the therapeutic potential of hematopoietic stem cell transplantation
по: Amjad Ahmed Aljagthmi, и др.
Опубликовано: (2025-02-01)

Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells
по: Alix K. Berglund, и др.
Опубликовано: (2017-12-01)

Elimination of the immunogenicity of therapeutic antibodies.
по: Gilliland, L, и др.
Опубликовано: (1999)

Enhancing human regulatory T cells in vitro for cell therapy applications
по: Milward, K, и др.
Опубликовано: (2017)

Modulation of CD27/CD70 co-stimulatory pathway may allow for the generation of a more potent human regulatory T cell product for cell therapy
по: Arroyo Hornero, R, и др.
Опубликовано: (2017)

The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives
по: Xin Liu, и др.
Опубликовано: (2017-06-01)

Understanding menstrual blood-derived stromal/stem cells: Definition and properties. Are we rushing into their therapeutic applications?
по: Alicia Sanchez-Mata, и др.
Опубликовано: (2021-12-01)

Stem cells and cancer stem cells : therapeutic applications in disease and injury /
по: Hayat, M. A., 1940-
Опубликовано: (c201)

Editorial: Immunogenicity of Proteins Used as Therapeutics
по: Zuben E. Sauna, и др.
Опубликовано: (2020-10-01)

Tissue targeted regulatory T cell therapy prevents human skin allograft rejection in a humanised mouse model
по: Issa, F, и др.
Опубликовано: (2013)

Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses
по: Zaitsu, M, и др.
Опубликовано: (2017)

Stem cells : nuclear reprogramming and therapeutic applications /
по: Bock, Gregory, и др.
Опубликовано: (2005)

Immunogenicity of undifferentiated and differentiated allogeneic mouse mesenchymal stem cells
по: Blessing Mukonoweshuro, и др.
Опубликовано: (2014-04-01)

Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation.
по: Ding, Y, и др.
Опубликовано: (2010)

Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less immunogenic somatic cells.
по: Pengfei Liu, и др.
Опубликовано: (2013-01-01)

Recent advances in our understanding of the allograft response
по: Hennessy, C, и др.
Опубликовано: (2021)

Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.
по: Tseng, S, и др.
Опубликовано: (2009)

Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicity
по: Michel Siegel, и др.
Опубликовано: (2024-08-01)

Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells.
по: Xiaoying Wang, и др.
Опубликовано: (2014-01-01)

Understanding the application of stem cell therapy in cardiovascular diseases
по: Sharma RK, и др.
Опубликовано: (2012-10-01)

Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
по: Jasmine Davda, и др.
Опубликовано: (2019-04-01)

Stem cells and cancer stem cells, volume 12 : therapeutic applications in disease and injury /
по: Hayat, M. A., 1940- , editor
Опубликовано: (2014)

Low Immunogenicity of Keratinocytes Derived from Human Embryonic Stem Cells
по: Jiayi Shen, и др.
Опубликовано: (2024-08-01)

Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells
по: Tobias Deuse, и др.
Опубликовано: (2011-06-01)

The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
по: Li Zhang, и др.
Опубликовано: (2015-01-01)

Molecular Imaging of Stem Cells: Tracking Survival, Biodistribution, Tumorigenicity, and Immunogenicity
по: Eugene Gu, Wen-Yi Chen, Jay Gu, Paul Burridge, Joseph C. Wu
Опубликовано: (2012-01-01)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients
по: Bottomley, M, и др.
Опубликовано: (2022)

Stem Cells Applications in Regenerative Medicine and Disease Therapeutics
по: Ranjeet Singh Mahla
Опубликовано: (2016-01-01)